World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 5.922

ICV : 78.6

Abstract

PREVENTION OF PRE-ECLAMPSIA AND GESTATIONAL DIABETES MELLITUS: AN INTERVENTIONAL CONCEPT OF PATIENT COUNSELING IN PREGNANT WOMEN

Shruti Rai*, Dr. Jalpa Soni, Poonam Patel and Dr. I. S. Anand

ABSTRACT

In pregnancy, hypertension and gestational diabetes mellitus are major causes of various maternal and fetal complications. Pre-eclampsia (PE) is transient type of hypertensive disorder. It is a multi-system disorder which is presented as hypertension and involvement of other organ systems and/or the fetus. Mainly it includes raised BP and proteinuria as the first manifestation. Pre-eclampsia is the third leading cause of pregnancy related maternal and fetal morbidity and mortality. Gestational Diabetes Mellitus (GDM) is pregnancy induced glucose tolerance which is first recognized during pregnancy usually develops between 24th to 28th gestational weeks, but might develop sooner or later. It is more common in women who are overweight, older and less active or have a family history of diabetes. Pre-eclampsia and gestational diabetes mellitus should be prevented before its onset, to limit the maternal and fetal complications and deaths. Patient counseling is a major tool to prevent pre-eclampsia and gestational diabetes mellitus. Many studies have shown that patient counseling helps in prevention of pre-eclampsia and gestational diabetes mellitus. Interventions can be done by counseling patients about lifestyle modifications, dietary changes and physical activity.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR